About neoX Biotech
neoX Biotech is a company based in Pudong (China) founded in 2018 by Fan Liu and Michael Chen.. neoX Biotech has raised $40 million across 4 funding rounds from investors including Sequoia Capital, Sky9 Capital and BAI Capital. neoX Biotech operates in a competitive market with competitors including Relay Therapeutics, Atomwise, Genesis Therapeutics, Unnatural Products and Celeris Therapeutics, among others.
- Headquarter Pudong, China
- Founders Fan Liu, Michael Chen
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$40 M (USD)
in 4 rounds
-
Latest Funding Round
-
Investors
Sequoia Capital
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of neoX Biotech
neoX Biotech has successfully raised a total of $40M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Last Round
- First Round First Round
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Series A - neoX Biotech | Valuation | Sequoia Capital China | |
| Feb, 2021 | Amount | Series A - neoX Biotech | Valuation | Sky9 Capital , 5Y Capital | |
| Jul, 2020 | Amount | Seed - neoX Biotech | Valuation | Sequoia Capital , Vision Plus Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in neoX Biotech
neoX Biotech has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Sequoia Capital, Sky9 Capital and BAI Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech investments are made stage-agnostically in China and the US.
|
Founded Year | Domain | Location | |
|
A venture capital firm focused on technology and innovation investments.
|
Founded Year | Domain | Location | |
|
Sequoia Capital is engaged in venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by neoX Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - neoX Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Neox Biotech Comparisons
Competitors of neoX Biotech
neoX Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Relay Therapeutics, Atomwise, Genesis Therapeutics, Unnatural Products and Celeris Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug discovery platform is developed to study protein motion.
|
|
| domain | founded_year | HQ Location |
AI-driven platform for structure-based drug discovery is provided.
|
|
| domain | founded_year | HQ Location |
Computational platform for AI-driven small molecule drug discovery is developed.
|
|
| domain | founded_year | HQ Location |
Peptides are engineered via computational biology for undruggable targets.
|
|
| domain | founded_year | HQ Location |
An AI-driven degrader platform for drug discovery is developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Neox Biotech
Frequently Asked Questions about neoX Biotech
When was neoX Biotech founded?
neoX Biotech was founded in 2018.
Where is neoX Biotech located?
neoX Biotech is headquartered in Pudong, China. It is registered at Pudong, Shanghai, China.
Who is the current CEO of neoX Biotech?
Michael Chen is the current CEO of neoX Biotech. They have also founded this company.
Is neoX Biotech a funded company?
neoX Biotech is a funded company, having raised a total of $40M across 4 funding rounds to date. The company's 1st funding round was a Seed of $10M, raised on Jun 01, 2018.
What does neoX Biotech do?
Founded in 2018 and based in Pudong, China, neoX Biotech operates in the biotechnology sector. Research and characterization of protein-protein interactions are provided to support drug discovery processes. Artificial intelligence, biophysics, and high-throughput experimentation are integrated to uncover macromolecular and multi-specific drug modalities. Insights into dynamic protein-protein interactions are emphasized throughout operations.
Who are the top competitors of neoX Biotech?
neoX Biotech's top competitors include Atomwise, Genesis Therapeutics and Unnatural Products.
Who are neoX Biotech's investors?
neoX Biotech has 8 investors. Key investors include Sequoia Capital, Sky9 Capital, BAI Capital, 5Y Capital, and Sequoia Capital.